Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IL6 |
| Upstream (Parents) |
|---|
| (<<) ADAM12 → IL6 |
| (<<) CHST3 → IL6 |
| (<<) CYR61 → IL6 |
| (<<) FOS → IL6 |
| (<<) HIF1A → IL6 |
| (<<) ITGA7 → IL6 |
| (<<) JAK2 → IL6 |
| (<<) KRTAP1-3 → IL6 |
| (<<) MAP1B → IL6 |
| (<<) MMP1 → IL6 |
| (<<) MMP19 → IL6 |
| (<<) NFKBIE → IL6 |
| (<<) NRIP3 → IL6 |
| (<<) ROCK1 → IL6 |
| (<<) SLC20A1 → IL6 |
| (<<) UPP1 → IL6 |
| Downstream (Children) |
|---|
| IL6 → KLF10 (>>) |
| IL6 → NFIB (>>) |
| IL6 → PFKFB3 (>>) |
| IL6 → PTGS2 (>>) |
| IL6 → SIGLEC15 (>>) |
| IL6 → TINF2 (>>) |
